Janus Henderson Group Plc - Dec 31, 2024 SCHEDULE 13G/A Report for MONOPAR THERAPEUTICS INC Common Stock (MNPR)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
MONOPAR THERAPEUTICS INC Common Stock
Symbol
MNPR
Shares outstanding
6.09M shares
Disclosed Ownership
1.05M shares
Ownership
17.2%
Form type
SCHEDULE 13G/A
Date filed
1/8/2025, 11:38 AM
Date of event
Dec 31, 2024
Next filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 17.2% 1.05M 0 1.05M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 15.6% 953K 0 953K Kristin Mariani Head of North America Compliance, CCO